Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Income from Continuing Operations (2023 - 2025)

Upstream Bio has reported Income from Continuing Operations over the past 3 years, most recently at 42513000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 42513000.0 for Q4 2025, down 100.14% from a year ago — trailing twelve months through Dec 2025 was 143428000.0 (down 118.5% YoY), and the annual figure for FY2025 was 143428000.0, down 118.5%.
  • Income from Continuing Operations for Q4 2025 was 42513000.0 at Upstream Bio, down from 33729000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for UPB hit a ceiling of 7859000.0 in Q3 2023 and a floor of 42513000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 3 years was 18615500.0 (2024), compared with a mean of 22973900.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 65.81% in 2024 and later crashed 172.22% in 2025.
  • Upstream Bio's Income from Continuing Operations stood at 12811000.0 in 2023, then plummeted by 65.81% to 21242000.0 in 2024, then tumbled by 100.14% to 42513000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 42513000.0 (Q4 2025), 33729000.0 (Q3 2025), and 39916000.0 (Q2 2025) per Business Quant data.